<DOC>
	<DOCNO>NCT01190878</DOCNO>
	<brief_summary>The purpose study evaluate ocular safety , tolerability , efficacy topical administration differ dose regimen ISV-303 compare vehicle Xibromâ„¢ dose 2 week post-cataract-surgery volunteer .</brief_summary>
	<brief_title>Study Compare Differing Dosing Regimens ISV-303 ( Bromfenac DuraSite ) Xibrom Vehicle Post Cataract Surgery Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Bromfenac</mesh_term>
	<criteria>Scheduled unilateral cataract surgery ( phacoemulsification extracapsular extraction ) posterior chamber intraocular lens implantation day prior study enrollment Meet best correct visual acuity score requirement Meet IOP requirement Additional inclusion criterion also apply Known hypersensitivity poor tolerance bromfenac sodium component study medication procedural medication Use ocular topical , systemic medication could interfere normal lacrimation , wound healing , test agent , interpretation study result , within 1 week prior Day Surgery Additional exclusion criterion also apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>